AVR
Anteris Technologies Global Corp. Common Stock
NASDAQ: AVR · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$6.15
+4.24% today
Updated 2026-04-30
Market cap
$542.55M
P/E ratio
—
P/S ratio
283.61x
EPS (TTM)
$-2.55
Dividend yield
—
52W range
$3 – $7
Volume
0.9M
Anteris Technologies Global Corp. Common Stock (AVR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | — | $-11.08M | $-14.44M | $-29.42M | $-34.63M | $-61.24M | $-77.80M |
| Capital expenditures | $0.00 | $222454.00 | $582235.00 | $1.67M | $2.39M | $2.27M | $1.95M |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | — | $323983.00 | $254850.00 | $2.94M | $5.76M | — | $7.78M |
| Free cash flow | — | $-11.30M | $-15.02M | $-31.08M | $-37.03M | $-63.51M | $-79.76M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |